Jason Haney to Dipeptidyl-Peptidase IV Inhibitors
This is a "connection" page, showing publications Jason Haney has written about Dipeptidyl-Peptidase IV Inhibitors.
Connection Strength
0.643
-
Outcomes Associated With the Adjunctive Use of Dipeptidyl Peptidase-4 Inhibitors With Insulin Versus Other Antihyperglycemic Medications in Patients With Prediabetes or Diabetes After Cardiac Surgery. J Pharm Pract. 2021 Apr; 34(2):259-264.
Score: 0.643